{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:57:56Z","timestamp":1768507076851,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022840","name":"Serum Institute of India Private Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128109","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:09:34Z","timestamp":1765584574000},"page":"128109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunogenicity and non-inferiority evaluation of dose-sparing adjuvanted inactivated polio vaccine in Wistar rats"],"prefix":"10.1016","volume":"72","author":[{"given":"Jagdish K.","family":"Zade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sambhaji S.","family":"Pisal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parikshit","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus S.","family":"Poonawalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijeet","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyaprasad","family":"Manney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varun","family":"Datar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpesh","family":"Vidhate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh B.","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev M.","family":"Dhere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128109_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41586-020-03045-2","article-title":"New polio vaccine poised to get emergency WHO approval","volume":"587","author":"Irwin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.128109_bb0010","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.128109_bb0020","unstructured":"World Health Organization. Polio Eradication Strategy 2022\u20132026: Delivering on a promise, 2021. Available from: https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/06\/Polio-Eradication-Strategy-2022-2026-Delivering-on-a-Promise.pdf."},{"key":"10.1016\/j.vaccine.2025.128109_bb0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2025.128109_bb0030","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa0910074","article-title":"Implications of a circulating vaccine-derived poliovirus in Nigeria","volume":"362","author":"Jenkins","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128109_bb0035","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.vaccine.2025.128109_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0002920","article-title":"One billion doses and WHO prequalification of nOPV2: implications for the global polio situation and beyond","volume":"4","author":"Bandyopadhyay","year":"2024","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/j.vaccine.2025.128109_bb0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.chom.2020.04.003","article-title":"Engineering the live-attenuated polio vaccine to prevent reversion to virulence","volume":"27","author":"Yeh","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128109_bb0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1586\/14760584.2016.1140041","article-title":"Polio endgame: the global switch from tOPV to bOPV","volume":"15","author":"Garon","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.128109_bb0055","author":"Pan American Health Organization"},{"key":"10.1016\/j.vaccine.2025.128109_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4161\/hv.3.4.4309","article-title":"Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice","volume":"3","author":"Caulfield","year":"2007","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2025.128109_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-018-0089-x","article-title":"Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want","volume":"3","author":"HogenEsch","year":"2018","journal-title":"NPJ Vacc"},{"key":"10.1016\/j.vaccine.2025.128109_bb0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2025.128109_bb0075","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1016\/j.vaccine.2012.09.059","article-title":"Adjuvants and inactivated polio vaccine: a systematic review","volume":"30","author":"Hawken","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128109_bb0080","author":"WHO"},{"key":"10.1016\/j.vaccine.2025.128109_bb0085","author":"WHO"},{"key":"10.1016\/j.vaccine.2025.128109_bb0090","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.128109_bb0095","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1093\/infdis\/jiu128","article-title":"Affordable inactivated poliovirus vaccine: strategies and progress","volume":"210","author":"Okayasu","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128109_bb0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2013.05.007","article-title":"Poliovirus vaccination options for achieving eradication and securing the endgame","volume":"3","author":"Est\u00edvariz","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2025.128109_bb0105","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.ijid.2011.10.002","article-title":"Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines","volume":"16","author":"Cadorna-Carlos","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128109_bb0110","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128109_bb0115","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.vaccine.2016.12.027","volume":"35","author":"Lindgren","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128109_bb0120","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/erv.11.72","article-title":"A DTaP-IPV\/\/PRP approximately T vaccine (Pentaxim): a review of 16 years\u2019 clinical experience","volume":"10","author":"Plotkin","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.128109_bb0125","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.vaccine.2003.09.011","article-title":"Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells","volume":"22","author":"Haastrup","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128109_bb0130","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1016\/j.vaccine.2008.07.033","article-title":"Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3\u00b75, 5 and 16 months of age","volume":"26","author":"Pietrzyk","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128109_bb0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0264-410X(91)90154-X","article-title":"Predicting the adsorption of proteins by aluminum-containing adjuvants","volume":"9","author":"Seeber","year":"1991","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2025.128109_bb0140","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0264-410X(02)00169-X","article-title":"Mechanisms of stimulation of the immune response by aluminum adjuvants","volume":"20","author":"HogenEsch","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128109_bb0145","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.vaccine.2015.02.011","article-title":"Aluminium hydroxide potentiates a protective Th1 biased immune response against polio virus that allows for dose sparing in mice and rats","volume":"33","author":"Andreasen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128109_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0264-410X(88)90006-0","article-title":"Stability of Oral polio vaccine at different temperatures","volume":"6","author":"Sokhey","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128109_bb0155","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virol.2015.03.005","article-title":"Effect of time at temperature on wild poliovirus titers in stool specimens","volume":"482","author":"At","year":"2015","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128109_bb0160","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1473-3099(25)00215-4","article-title":"Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial","volume":"25","author":"Kulkarni","year":"2025","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:54:31Z","timestamp":1768452871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"alternative-id":["S0264410X25014070"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128109","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and non-inferiority evaluation of dose-sparing adjuvanted inactivated polio vaccine in Wistar rats","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128109"}}